Insulin, insulin-like growth factors 1 and 2 (IGF-1 and -2, respectively), and their receptors (IR and IGF-1R) are the key elements of a complex hormonal system that is essential for the development and functioning of humans. The C and D domains of IGFs (absent in insulin) likely play important roles in the differential binding of IGF-1 and -2 to IGF-1R and to the isoforms of IR (IR-A and IR-B) and specific activation of these receptors. Here, we attempted to probe the impact of IGF-1 and IGF-2 D domains (DI and DII, respectively) and the IGF-2 C domain (CII) on the receptor specificity of these hormones. For this, we made two types of insulin hybrid analogues: (i) with the C-terminus of the insulin A chain extended by the amino acids from the DI and DII domains and (ii) with the C-terminus of the insulin B chain extended by some amino acids derived from the CII domain. The receptor binding affinities of these analogues and their receptor autophosphorylation potentials were characterized. Our results indicate that the DI domain has a more negative impact than the DII domain does on binding to IR, and that the DI domain Pro-Leu-Lys residues are important factors for a different IR-A versus IR-B binding affinity of IGF-1. We also showed that the additions of amino acids that partially "mimic" the CII domain, to the C-terminus of the insulin B chain, change the binding and autophosphorylation specificity of insulin in favor of the "metabolic" IR-B isoform. This opens new venues for rational enhancement of insulin IR-B specificity by modifications beyond the C-terminus of its B chain.

Charles University Prague Faculty of Science Department of Biochemistry Hlavova 8 128 43 Praha 2 Czech Republic

Institute of Organic Chemistry and Biochemistry Academy of Science of the Czech Republic v v i Flemingovo nám 2 166 10 Praha 6 Czech Republic

York Structural Biology Laboratory Department of Chemistry University of York Heslington York YO10 5DD United Kingdom

References provided by Crossref.org

A viral insulin-like peptide inhibits IGF-1 receptor phosphorylation and regulates IGF1R gene expression

Insulin receptor Arg717 and IGF-1 receptor Arg704 play a key role in ligand binding and in receptor activation

Modulation of the antagonistic properties of an insulin mimetic peptide by disulfide bridge modifications

Characterization of viral insulins reveals white adipose tissue-specific effects in mice

A radioligand binding assay for the insulin-like growth factor 2 receptor

Mutations at hypothetical binding site 2 in insulin and insulin-like growth factors 1 and 2 result in receptor- and hormone-specific responses

A versatile insulin analog with high potency for both insulin and insulin-like growth factor 1 receptors: Structural implications for receptor binding

Structural Perspectives of Insulin Receptor Isoform-Selective Insulin Analogs

Probing Receptor Specificity by Sampling the Conformational Space of the Insulin-like Growth Factor II C-domain